Huons Co. Ltd (243070) - Total Assets
Based on the latest financial reports, Huons Co. Ltd (243070) holds total assets worth ₩644.23 Billion KRW (≈ $436.59 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Huons Co. Ltd book value and equity for net asset value and shareholders' equity analysis.
Huons Co. Ltd - Total Assets Trend (2016–2024)
This chart illustrates how Huons Co. Ltd's total assets have evolved over time, based on quarterly financial data.
Huons Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Huons Co. Ltd's total assets of ₩644.23 Billion consist of 42.4% current assets and 57.6% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩54.17 Billion | 8.9% |
| Accounts Receivable | ₩95.45 Billion | 15.7% |
| Inventory | ₩76.25 Billion | 12.6% |
| Property, Plant & Equipment | ₩246.82 Billion | 40.7% |
| Intangible Assets | ₩7.11 Billion | 1.2% |
| Goodwill | ₩4.08 Billion | 0.7% |
Asset Composition Trend (2016–2024)
This chart illustrates how Huons Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Huons Co. Ltd.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Huons Co. Ltd's current assets represent 42.4% of total assets in 2024, a decrease from 67.3% in 2016.
- Cash Position: Cash and equivalents constituted 8.9% of total assets in 2024, up from 8.9% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, unchanged from 1.0% in 2016.
- Asset Diversification: The largest asset category is property, plant & equipment at 40.7% of total assets.
Huons Co. Ltd Competitors by Total Assets
Key competitors of Huons Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥31.46 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535
|
China | CN¥15.34 Billion |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
China | CN¥15.32 Billion |
|
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
|
China | CN¥10.96 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
Huons Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.82 | 1.69 | 2.14 |
| Quick Ratio | 1.24 | 1.14 | 1.64 |
| Cash Ratio | 0.00 | 0.36 | 0.00 |
| Working Capital | ₩128.99 Billion | ₩103.50 Billion | ₩142.64 Billion |
Huons Co. Ltd - Advanced Valuation Insights
This section examines the relationship between Huons Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.89 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 12.8% |
| Total Assets | ₩606.29 Billion |
| Market Capitalization | $208.46 Million USD |
Valuation Analysis
Below Book Valuation: The market values Huons Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Huons Co. Ltd's assets grew by 12.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Huons Co. Ltd (2016–2024)
The table below shows the annual total assets of Huons Co. Ltd from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩606.29 Billion ≈ $410.87 Million |
+12.84% |
| 2023-12-31 | ₩537.29 Billion ≈ $364.11 Million |
+13.68% |
| 2022-12-31 | ₩472.63 Billion ≈ $320.29 Million |
+8.18% |
| 2021-12-31 | ₩436.90 Billion ≈ $296.08 Million |
+4.90% |
| 2020-12-31 | ₩416.50 Billion ≈ $282.26 Million |
+38.68% |
| 2019-12-31 | ₩300.34 Billion ≈ $203.54 Million |
+19.48% |
| 2018-12-31 | ₩251.37 Billion ≈ $170.35 Million |
+16.38% |
| 2017-12-31 | ₩216.00 Billion ≈ $146.38 Million |
+20.44% |
| 2016-12-31 | ₩179.34 Billion ≈ $121.54 Million |
-- |
About Huons Co. Ltd
Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, anti-coagulant, antiviral, central nervous system, antibiotic, well-being, urogenital system, and other ch… Read more